Adaptive Biotechnologies Corporation (ADPT): Price and Financial Metrics
ADPT Price/Volume Stats
| Current price | $4.42 | 52-week high | $6.70 |
| Prev. close | $4.48 | 52-week low | $2.28 |
| Day low | $4.33 | Volume | 1,819,500 |
| Day high | $4.57 | Avg. volume | 1,409,832 |
| 50-day MA | $4.96 | Dividend yield | N/A |
| 200-day MA | $3.99 | Market Cap | 652.30M |
ADPT Stock Price Chart Interactive Chart >
Adaptive Biotechnologies Corporation (ADPT) Company Bio
Adaptive Biotechnologies Corp. engages in the development of an immune medicine platform. It harnesses the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its products and services include immunoSEQ, clonoSEQ, cellular therapy, and vaccines. The company was founded by Chad Robins, Harlan Robins, and Chris Carlson in September 2009 and is headquartered in Seattle, WA.
ADPT Price Returns
| 1-mo | -5.96% |
| 3-mo | -9.05% |
| 6-mo | 28.49% |
| 1-year | 4.00% |
| 3-year | -83.23% |
| 5-year | -84.57% |
| YTD | -9.80% |
| 2023 | -35.86% |
| 2022 | -72.77% |
| 2021 | -52.55% |
| 2020 | 97.63% |
| 2019 | N/A |
Loading social stream, please wait...